ES2312828T3 - Inmunoensayo no competitivo para analitos pequeños. - Google Patents
Inmunoensayo no competitivo para analitos pequeños. Download PDFInfo
- Publication number
- ES2312828T3 ES2312828T3 ES03773761T ES03773761T ES2312828T3 ES 2312828 T3 ES2312828 T3 ES 2312828T3 ES 03773761 T ES03773761 T ES 03773761T ES 03773761 T ES03773761 T ES 03773761T ES 2312828 T3 ES2312828 T3 ES 2312828T3
- Authority
- ES
- Spain
- Prior art keywords
- binding partner
- analyte
- seq
- binding
- fab
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/44—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material not provided for elsewhere, e.g. haptens, metals, DNA, RNA, amino acids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/536—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
- G01N33/542—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with steric inhibition or signal modification, e.g. fluorescent quenching
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6854—Immunoglobulins
- G01N33/6857—Antibody fragments
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
- G01N33/946—CNS-stimulants, e.g. cocaine, amphetamines
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
- G01N33/948—Sedatives, e.g. cannabinoids, barbiturates
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
- G01N33/9486—Analgesics, e.g. opiates, aspirine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
- C07K2317/62—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
- C07K2317/622—Single chain antibody (scFv)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2470/00—Immunochemical assays or immunoassays characterised by the reaction format or reaction type
- G01N2470/04—Sandwich assay format
- G01N2470/06—Second binding partner specifically binding complex of analyte with first binding partner
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Cell Biology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pain & Pain Management (AREA)
- Anesthesiology (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Emergency Medicine (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Wrappers (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FI20022048 | 2002-11-18 | ||
| FI20022048A FI20022048A0 (fi) | 2002-11-18 | 2002-11-18 | Ei-kompetetiivinen immunomääritys pienille analyyteille |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2312828T3 true ES2312828T3 (es) | 2009-03-01 |
Family
ID=8564953
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES03773761T Expired - Lifetime ES2312828T3 (es) | 2002-11-18 | 2003-11-17 | Inmunoensayo no competitivo para analitos pequeños. |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US7749712B2 (no) |
| EP (1) | EP1579222B8 (no) |
| JP (1) | JP4729701B2 (no) |
| CN (1) | CN1711476B (no) |
| AT (1) | ATE408146T1 (no) |
| BR (1) | BRPI0316384B8 (no) |
| CA (1) | CA2503509C (no) |
| DE (1) | DE60323538D1 (no) |
| DK (1) | DK1579222T3 (no) |
| EA (1) | EA200500643A1 (no) |
| ES (1) | ES2312828T3 (no) |
| FI (1) | FI20022048A0 (no) |
| MX (1) | MXPA05005288A (no) |
| NO (1) | NO338417B1 (no) |
| NZ (1) | NZ539714A (no) |
| WO (1) | WO2004046733A1 (no) |
| ZA (1) | ZA200503475B (no) |
Families Citing this family (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030109067A1 (en) * | 2001-12-06 | 2003-06-12 | Immunetech, Inc. | Homogeneous immunoassays for multiple allergens |
| JP2007040834A (ja) * | 2005-08-03 | 2007-02-15 | Japan Science & Technology Agency | 免疫測定用試薬 |
| FI20075251A0 (fi) | 2007-04-13 | 2007-04-13 | Hytest Oy | Immunomääritys epästabiilien antigeenien määrittämiseksi |
| GB0707870D0 (en) * | 2007-04-23 | 2007-05-30 | Selected Antibodies Ltd | Assay Devices and Methods and Components for use Therein |
| ES2373009T3 (es) * | 2007-12-18 | 2012-01-30 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Morfina endógena o un metabolito de origen natural de la misma como marcador para septicemia. |
| GB0725234D0 (en) * | 2007-12-24 | 2008-02-06 | Oxtex Ltd | Electrochemical assays |
| CA2719036A1 (en) * | 2008-04-02 | 2009-10-08 | Vivacta Ltd | A method for sensing a chemical |
| US8093018B2 (en) * | 2008-05-20 | 2012-01-10 | Otsuka Pharmaceutical Co., Ltd. | Antibody identifying an antigen-bound antibody and an antigen-unbound antibody, and method for preparing the same |
| FI20085579A0 (fi) * | 2008-06-12 | 2008-06-12 | Valtion Teknillinen | Kannabiskäytön toteaminen |
| DE102008049601A1 (de) * | 2008-09-30 | 2010-04-01 | Siemens Healthcare Diagnostics Products Gmbh | Antikörper zur Bestimmung des Prothrombin-Fragments F2/F1+2 in einem homogenen Immunoassay |
| MY151976A (en) * | 2009-07-21 | 2014-07-31 | Sekisui Medical Co Ltd | Insulin assay |
| WO2011053783A2 (en) * | 2009-10-30 | 2011-05-05 | Merck Sharp & Dohme Corp. | Ax213 and ax132 pcsk9 antagonists and variants |
| EP2515110B1 (en) * | 2009-11-19 | 2015-03-25 | Ushio Denki Kabushiki Kaisha | Fluoroimmunoassay method |
| US8883978B2 (en) | 2010-05-11 | 2014-11-11 | Institute For Cancer Research | Antibodies to tumor endothelial marker 7R |
| US9599608B2 (en) * | 2011-09-21 | 2017-03-21 | Fujirebio Inc. | Antibody against affinity complex |
| US20130102003A1 (en) * | 2011-10-21 | 2013-04-25 | Decimadx, Llc | Point-of-Care Immunoassay for Quantitative Small Analyte Detection |
| EP2637021A1 (de) | 2012-03-06 | 2013-09-11 | Securetec Detektions-Systeme AG | Verfahren und Vorrichtung zum Nachweis von Analyten |
| US9804161B1 (en) | 2012-05-14 | 2017-10-31 | Lawrence Livermore National Security, Llc | Detector and related, devices, methods and systems |
| EP2722669A1 (de) | 2012-10-22 | 2014-04-23 | Securetec Detektions-Systeme AG | Verfahren und Vorrichtung zum Nachweis von illegalen Drogen |
| JP6673895B2 (ja) | 2014-03-21 | 2020-03-25 | エスティー アンド ティー インターナショナル，インコーポレイティド | アサ属抽出方法及び組成物 |
| FI126746B (en) | 2014-04-07 | 2017-05-15 | Teknologian Tutkimuskeskus Vtt Oy | Antibody to HT-2 toxin-HT-2 toxin antibody complex |
| WO2017053567A1 (en) * | 2015-09-22 | 2017-03-30 | Delta Tm Technologies | Designing customized protein-specific buffer systems |
| US10954500B2 (en) | 2015-10-23 | 2021-03-23 | Fred Hutchinson Cancer Research Center | Methods to create chemically-induced dimerizing protein systems for regulation of cellular events |
| US10808024B2 (en) | 2015-12-21 | 2020-10-20 | Turun Yliopisto | Antibodies against immunocomplexes comprising cyanobacterial cyclic peptide hepatotoxins |
| EP3954376A1 (en) * | 2016-01-22 | 2022-02-16 | Affimedix, Inc. | Method for quantification of vitamin d metabolites |
| US11435367B2 (en) * | 2016-07-29 | 2022-09-06 | Diazyme Laboratories, Inc. | Methods and kits for assaying a vitamin D moiety |
| IL294218A (en) | 2019-12-27 | 2022-08-01 | Chiome Bioscience Inc | Antibody against cdcp1 |
| WO2022049867A1 (ja) | 2020-09-02 | 2022-03-10 | 国立大学法人東京大学 | がん免疫微小環境の調節物質およびそれによる予防・診断・治療的利用 |
| CA3239740A1 (en) * | 2021-12-03 | 2023-06-08 | Tim C. LEUTKENS | High selective cd229 antigen binding domains and methods of use |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3996345A (en) * | 1974-08-12 | 1976-12-07 | Syva Company | Fluorescence quenching with immunological pairs in immunoassays |
| US5223441A (en) * | 1986-10-09 | 1993-06-29 | Syntex (U.S.A.) Inc. | Receptors for immune complexes |
| AU695406B2 (en) * | 1994-03-30 | 1998-08-13 | Igen International, Inc. | The isolation and production of catalytic antibodies using phage technology |
| JP3025633B2 (ja) * | 1995-12-05 | 2000-03-27 | 株式会社蛋白工学研究所 | グルタチオン結合活性を有するポリペプチド及びその製造方法 |
| JP4228095B2 (ja) | 1999-12-17 | 2009-02-25 | 東ソー株式会社 | 免疫測定方法および免疫測定試薬 |
| CN1136450C (zh) * | 2000-11-03 | 2004-01-28 | 厦门大学 | 具有荧光共振能量转移特征的成对蛋白及其用途 |
-
2002
- 2002-11-18 FI FI20022048A patent/FI20022048A0/fi unknown
-
2003
- 2003-11-17 NZ NZ539714A patent/NZ539714A/en not_active IP Right Cessation
- 2003-11-17 AT AT03773761T patent/ATE408146T1/de not_active IP Right Cessation
- 2003-11-17 US US10/535,260 patent/US7749712B2/en active Active
- 2003-11-17 EP EP03773761A patent/EP1579222B8/en not_active Expired - Lifetime
- 2003-11-17 MX MXPA05005288A patent/MXPA05005288A/es active IP Right Grant
- 2003-11-17 EA EA200500643A patent/EA200500643A1/ru unknown
- 2003-11-17 BR BRPI0316384A patent/BRPI0316384B8/pt active IP Right Grant
- 2003-11-17 CA CA2503509A patent/CA2503509C/en not_active Expired - Lifetime
- 2003-11-17 ES ES03773761T patent/ES2312828T3/es not_active Expired - Lifetime
- 2003-11-17 DK DK03773761T patent/DK1579222T3/da active
- 2003-11-17 DE DE60323538T patent/DE60323538D1/de not_active Expired - Lifetime
- 2003-11-17 JP JP2004552756A patent/JP4729701B2/ja not_active Expired - Lifetime
- 2003-11-17 WO PCT/FI2003/000875 patent/WO2004046733A1/en active IP Right Grant
- 2003-11-17 CN CN2003801034664A patent/CN1711476B/zh not_active Expired - Lifetime
-
2005
- 2005-04-29 ZA ZA200503475A patent/ZA200503475B/en unknown
- 2005-06-13 NO NO20052849A patent/NO338417B1/no not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| CN1711476A (zh) | 2005-12-21 |
| US7749712B2 (en) | 2010-07-06 |
| EP1579222A1 (en) | 2005-09-28 |
| BR0316384A (pt) | 2005-10-04 |
| ZA200503475B (en) | 2006-07-26 |
| NO20052849L (no) | 2005-06-13 |
| AU2003282143A1 (en) | 2004-06-15 |
| BRPI0316384B8 (pt) | 2021-07-27 |
| NZ539714A (en) | 2007-03-30 |
| JP4729701B2 (ja) | 2011-07-20 |
| WO2004046733A1 (en) | 2004-06-03 |
| BRPI0316384B1 (pt) | 2016-07-05 |
| US20060246506A1 (en) | 2006-11-02 |
| EA200500643A1 (ru) | 2005-12-29 |
| FI20022048A0 (fi) | 2002-11-18 |
| EP1579222B8 (en) | 2009-01-07 |
| CN1711476B (zh) | 2010-09-08 |
| EP1579222B1 (en) | 2008-09-10 |
| DK1579222T3 (da) | 2008-11-17 |
| NO338417B1 (no) | 2016-08-15 |
| ATE408146T1 (de) | 2008-09-15 |
| MXPA05005288A (es) | 2005-08-16 |
| JP2006506634A (ja) | 2006-02-23 |
| CA2503509A1 (en) | 2004-06-03 |
| DE60323538D1 (de) | 2008-10-23 |
| CA2503509C (en) | 2013-02-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2312828T3 (es) | Inmunoensayo no competitivo para analitos pequeños. | |
| US8518653B2 (en) | Detection of cannabis use | |
| US8802382B2 (en) | Cobalamin assay | |
| CN100593721C (zh) | 用于病人的样本中生物化学标记物的早期和同步检测的免疫测定法和试剂盒 | |
| ES2709823T3 (es) | Anticuerpo contra el complejo de toxina HT-2-anticuerpo de toxina HT-2 | |
| AU2003282143B2 (en) | Non-competitive immunoassay for small analytes | |
| JP5641464B2 (ja) | 抗チロキシン抗体及びそれを用いた免疫測定方法 | |
| CN116874595A (zh) | 一种抗甲胎蛋白的纳米抗体、试剂盒及应用 | |
| CN116948027A (zh) | 一种抗降钙素原的纳米抗体、试剂盒及应用 | |
| CN116514985A (zh) | 一种抗前列腺特异性抗原的纳米抗体及其应用 | |
| EP3953381A1 (en) | Fusion protein comprising nanoluciferase inserted between immunoglobulin variable domains | |
| US20090311690A1 (en) | Vector for screening antibody |